Hubert van Hoogstraten

Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial

Gerd R Burmester, Yong Lin, Rahul Patel et al. · Annals of the Rheumatic Diseases · 2016 · 316 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study

Mark C. Genovese, Roy Fleischmann, Alan Kivitz et al. · Arthritis & Rheumatology · 2015 · 270 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Roy Fleischmann, Janet van Adelsberg, Yong Lin et al. · Arthritis & Rheumatology · 2016 · 210 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

Juliet N. Barker, Matthias Hoffmann, Gottfried Wozel et al. · British Journal of Dermatology · 2011 · 201 citations

Medicine, Pharmacology, Pharmacotherapy +12

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis

Paul Emery, Juan Rondon, Janie Parrino et al. · Lara D. Veeken · 2018 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13